An analytical study of iboga alkaloids contained in Tabernanthe iboga-derived products offered by ibogaine treatment providers. Archives of Clinical Psychiatry, [S. l.], v. 47, n. 2, p. 51–54, 2020. DOI: 10.1590/0101-60830000000231. Disponível em: https://www.revistas.usp.br/acp/article/view/180673.. Acesso em: 5 may. 2024.